Don’t miss the latest developments in business and finance.

Lupin drops after a block deal

Image
Capital Market
Last Updated : Sep 23 2013 | 11:55 PM IST

Lupin lost 0.82% to Rs 860.45 at 12:27 IST on BSE after a block deal of 3.21 lakh shares was executed on BSE at Rs 860.50 per share at 11:42 IST.

The block deal constitutes 0.07% of Lupin's equity.

Meanwhile, the S&P BSE Sensex was down 354.44 points or 1.75% at 19,909.27.

On BSE, 3.58 lakh shares were traded in the counter as against average daily volume of 1.13 lakh shares in the past one quarter.

The stock was volatile. The stock lost as much as 1.22% at the day's low of Rs 856.95 so far during the day. The stock rose as much as 1.31% at the day's high of Rs 879 so far during the day. The stock had hit a record high of Rs 908 on 19 July 2013. The stock had hit a 52-week low of Rs 540.15 on 11 October 2012.

The stock had outperformed the market over the past one month till 20 September 2013, surging 11.8% compared with the Sensex's 11.06% jump. The scrip had also outperformed the market in the past one quarter, jumping 11.35% as against Sensex's 8.25% rise.

More From This Section

The large-cap company has equity capital of Rs 89.60 crore. Face value per share is Rs 2.

Lupin's consolidated net profit surged 43% to Rs 401.06 crore on 9.1% growth in net sales to Rs 2420.66 crore in Q1 June 2013 over Q1 June 2012.

Lupin is a pharmaceutical company producing and developing a wide range of branded and generic formulations and active pharmaceutical ingredients.

Powered by Capital Market - Live News

Also Read

First Published: Sep 23 2013 | 12:26 PM IST

Next Story